Received Oct 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MEN | MENINGOCOCCAL (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT |
suffering from a medium case of SIRVA or myalgia, which is a broader term since his shoulder is not affected; Initial information received on 30-Sep-2025 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (non-healthcare professional). This case involves an unknown age male patient who had suffering from a medium case of sirva or myalgia, which is a broader term since his shoulder is not affected after receiving Meningococcal A-C-Y-W135 (T Conj) Vaccine [Menquadfi]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect Meningococcal A-C-Y-W135 (T Conj) Vaccine, Solution for injection (lot number, expiry date and strength not reported) via unknown route in unknown administration site for Immunization. On an unknown date, the patient developed suffering from a medium case of sirva or myalgia, which is a broader term since his shoulder is not affected (myalgia) (latency unknown) following the administration of Meningococcal A-C-Y-W135 (T Conj) Vaccine. Reportedly, patient was knowledgeable about adverse reaction and side effects and that he might be suffering from a medium case of sirva but then said that it might not be SIRVA since his shoulder is not affected. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event.